Nasal high-flow therapy delivers low level positive airway pressure

R Parke, S McGuinness, M Eccleston, R Parke, S McGuinness, M Eccleston

Abstract

Background: The aim of this prospective study was to determine whether a level of positive airway pressure was generated in participants receiving nasal high flow (NHF) delivered by the Optiflow system (Fisher and Paykel Healthcare Ltd, Auckland, New Zealand) in a cardiothoracic and vascular intensive care unit (ICU).

Methods: Nasopharyngeal airway pressure was measured in 15 postoperative cardiac surgery adult patients who received both NHF and standard facemask therapy at a flow rate of 35 litre min(-1). Measurements were repeated in the open mouth and closed mouth positions. Mean airway pressure was determined by averaging the pressures at the peak of inspiration of each breath within a 1 min period, allowing the entire pressure profile of each breath to be included within the calculation.

Results: Low level positive pressure was demonstrated with NHF at 35 litre min(-1) with mouth closed when compared with a facemask. NHF generated a mean nasopharyngeal airway pressure of mean (SD) 2.7 (1.04) cm H(2)O with the mouth closed. Airway pressure was significantly higher when breathing with mouth closed compared with mouth open (P<or=0.0001).

Conclusions: This study demonstrated that a low level of positive pressure was generated with NHF at 35 litre min(-1) of gas flow. This is consistent with results obtained in healthy volunteers. Australian Clinical Trials Registry www.actr.org.au ACTRN012606000139572.

Figures

Fig 1
Fig 1
Optiflow™ system set-up. a, Optiflow™ RT034 cannula; b, heater delivery tube RT241; c, MR880 heated humidifier; d, laptop interface; e, pressure transducer.
Fig 2
Fig 2
Standard facemask set-up. g, Mask adapter (commercially unavailable).
Fig 3
Fig 3
Breathing pressure profile of one participant over 1 min. Nasopharyngeal pressure (cm H2O) generated at 35 litre min−1 using NHF with the mouth closed (NHFMC) is shown in black. Nasopharyngeal pressure (cm H2O) generated at 35 litre min−1 using a facemask with the mouth closed (FMMC) is shown in grey.

References

    1. Kallstrom TJ. AARC clinical practice guideline: oxygen therapy for adults in the acute care facility—2002 revision & update. Respiratory Care. 2002;47:717–20.
    1. de Klerk A. Humidified high-flow nasal cannula: is it the new and improved CPAP? Adv Neonatal Care. 2008;8:98–106.
    1. Shoemaker MT, Pierce MR, Yoder BA, Digeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol. 2007;27:85–91.
    1. Saslow JG, Aghai ZH, Nakhla TA, et al. Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol. 2006;26:476–80.
    1. Lampland AL, Plumm B, Meyers PA, Worwa CT, Mammel MC. Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr. 2009;154:177–82.
    1. Kubicka ZJ, Limauro J, Darnall RA. Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics. 2008;121:82–8.
    1. McGinley BM, Patil SP, Kirkness JP, Smith PL, Schwartz AR, Schneider H. A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:194–200.
    1. Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007;20:126–31.
    1. Ritchie JE, Williams AB, Gerard C. Evaluation of a high flow nasal oxygenation system: gas analysis and pharyngeal pressures. Intensive Care Med. 2006;32:S219.
    1. Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics. 1993;91:135–8.
    1. Keenan SP, Kernerman PD, Cook DJ. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med. 1997;25:1685–92.

Source: PubMed

3
Iratkozz fel